Peptic Ulcer Disease News

• H Pylori Eradication Therapy Curbs Risk for Stomach Cancer Results of a large retrospective study support the potential for substantial stomach cancer prevention in the United States through H pylori screening and treatment.
  Medscape Medical News, May 05, 2023
• COVID Raises Risk for Long-Term GI Complications Overall, patients infected with the virus had a 36% higher risk of developing GI conditions.
  Medscape Medical News, March 13, 2023
• Can Particles in Dairy and Beef Cause Cancer and MS? A Nobel Prize winner suspects that bovine meat and milk factors may cause cancer, but scientific authorities are skeptical.
  Medscape Medical News, March 13, 2023
• New Lawsuits Target State Restrictions on Abortion Pills While the federal court lawsuits target specific state laws, they represent key legal tests that could eventually determine access to abortion for millions of women.
  Associated Press, January 25, 2023
• Scant Evidence for Proton Pump Inhibitor Role in Gastric Cancer Previous studies may not have accounted for the confounding role of the diseases for which the medications are prescribed.
  Medscape Medical News, January 12, 2023
• Vonoprazan Triple Therapy Most Cost-Effective for H pylori: Study In the United States, vonoprazan triple therapy has significant health and economic benefits relative to other first-line H pylori eradication regimens, with rifabutin triple therapy a close second.
  Medscape Medical News, December 29, 2022
• Call for Access to SABR for Inoperable Kidney Cancer Patients who have larger, inoperable kidney cancers and those unable to undergo surgery should be offered compassionate access to stereotactic ablative body radiotherapy (SABR), say experts.
  MDedge News, December 06, 2022
• Could There Be a Better Treatment for MS Relapses? A form of apheresis called immunoadsorption alleviates the symptoms better than the usual therapy with high-dose methylprednisolone, researchers found in a German study.
  Medscape Medical News, November 15, 2022
• The Changes Made in the New Expert Consensus on H pylori With the last update published in 2017, current consensus, released in August 2022, covers most of the latest progress made in the management of the infection.
  Medscape Medical News, November 15, 2022
• Time to Ditch Clarithromycin for H pylori? High clarithromycin resistance rates among H pylori isolates in the United States and Europe are grounds for arguing against its use in PPI-based triple therapy, researchers say.
  Medscape Medical News, October 21, 2022
• Search for Obesity Drugs; Long COVID; and Healthy Gut Microbiomes The top 3 things you should know to start your day.
  3 Things to Know Today, October 20, 2022
• Antioxidant-Rich Diet May Reduce H pylori Risk These are the latest data suggesting that balanced diets high in fruits and vegetables may provide an antioxidant environment allowing the body to fight off H pylori.
  Medscape Medical News, September 23, 2022
• Peptic Ulcer Risk in New Users of Low-Dose Aspirin New research finds a significantly increased risk for gastric and duodenal ulcers among adults starting low-dose aspirin therapy but not among peers who have been taking low-dose aspirin for some time.
  Medscape Medical News, June 15, 2022
• New German Guideline for H. pylori Infection Coming Soon The guideline will recommend for the first time that an infection be treated as soon as it is detected, regardless of whether the patient has symptoms.
  Medscape Medical News, June 09, 2022
• DDW 2022 H pylori Antibiotics Briefly Disrupt Gut Microbiome Researchers compared antibiotic resistance following either levofloxacin quadruple therapy or bismuth quadruple therapy.
  Medscape Medical News, May 27, 2022
• H pylori May Undermine Immunotherapy Response in Gastric Cancer H pylori infection was associated with shorter progression-free and overall survival. The study was published as a preprint and has not yet been peer reviewed.
  First Look, May 20, 2022
• Longer Use of Proton Pump Inhibitors Tied to Diabetes Risk 'Physicians should...avoid unnecessary prescription of this class of drugs, particularly for long-term use,' say study authors, but a gastroenterologist argues there isn't sufficient concern to alter practice.
  Medscape Medical News, May 04, 2022
• Cancer Deaths Continue to Fall in EU, UK, Led by Ovarian Cancer Mortality rates from most major cancers are predicted to continue falling in Europe and the UK in 2022, with a particularly striking reduction in deaths from ovarian cancer.
  Medscape Medical News, January 26, 2022
• Bead Embolization: a 'Bridge' to Bariatric Surgery? 'There is a real need to expand the weight loss treatments currently on offer for patients, especially those who don't want to go down a surgical route,' says a study author.
  Medscape Medical News, December 21, 2021
• Hemostatic Powder Noninferior in Nonvariceal Upper GI Bleeds TC-325 hemostatic powder compares well with standard endoscopic treatment of acute nonvariceal gastrointestinal bleeding in a new study.
  Medscape Medical News, December 08, 2021